Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Validation of new COMs for FSHD2 patients
Locations
9
Belgium
Leuven University
Leuven, Belgium
Nice University Hospital
Nice, Alpes M, France
APHM
Marseille, Bouches du Rhone, France
Myology Institute
Paris, Paris, France
Gemelli University Hospital
Rome, Lazio, Italy
Nemo Center
Milan, Lombardy, Italy
Start Date
October 3, 2023
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2026
Last Updated
October 9, 2024
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions